Harvard Mental Health Letter

References for "The glutamate hypothesis for schizophrenia"

Buchanan RW, et al. "The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments," American Journal of Psychiatry (Oct. 2007): Vol. 164, No. 10, pp. 1593–602. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17898352 Buchanan RW, et al. "Recent Advances in the Development of Novel Pharmacological Agents for the Treatment of Cognitive Impairments in Schizophrenia," Schizophrenia Bulletin (Sept. 2007): Vol. 33, No. 5, pp. 1120–30. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17641146 Coyle JT. "The Glutamatergic Dysfunction Hypothesis for Schizophrenia," Harvard Review of Psychiatry (Jan.–Feb. 1996): Vol. 3, No. 5, pp. 241–53. www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9384954
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »